These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 1850470)
1. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists. Murray CW; Cowan A J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470 [TBL] [Abstract][Full Text] [Related]
2. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
3. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324 [TBL] [Abstract][Full Text] [Related]
4. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. Roerig SC; Fujimoto JM J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350 [TBL] [Abstract][Full Text] [Related]
5. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269 [TBL] [Abstract][Full Text] [Related]
6. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460 [TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord. Machelska H; Labuz D; Przewłocki R; Przewłocka B J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366 [TBL] [Abstract][Full Text] [Related]
10. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899 [TBL] [Abstract][Full Text] [Related]
11. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. Cahill CM; White TD; Sawynok J J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600 [TBL] [Abstract][Full Text] [Related]
12. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids. Miaskowski C; Levine JD Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770 [TBL] [Abstract][Full Text] [Related]
13. Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test. Porreca F; Mosberg HI; Omnaas JR; Burks TF; Cowan A J Pharmacol Exp Ther; 1987 Mar; 240(3):890-4. PubMed ID: 3031278 [TBL] [Abstract][Full Text] [Related]
14. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676 [TBL] [Abstract][Full Text] [Related]
15. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus. Garaulet JV; Laorden ML; Milanés MV J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886 [TBL] [Abstract][Full Text] [Related]
16. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677 [TBL] [Abstract][Full Text] [Related]
17. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates. Fang FG; Fields HL; Lee NM J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217 [TBL] [Abstract][Full Text] [Related]
18. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice. Heyman JS; Mosberg HI; Porreca F NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989 [TBL] [Abstract][Full Text] [Related]
19. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice. Hong EK; Takemori AE J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928 [TBL] [Abstract][Full Text] [Related]
20. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions. Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]